Application

16252424 · METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY

Filed 2019-01-18 · Abandoned The official file ↗ · Art unit 1642 · Examiner Laura B Goddard Typical · CPC G01N 33/57415 · Cell Signaling Technology, Inc. · ROCHE RMS / KLARQUIST SPARKMAN, LLP

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

21.9 mo

to disposition 29.6 mo

Statutes raised

103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.